InvestLog
Back to Market返回行情

PBLS Parabilis Medicines, Inc.

NASDAQHealthcare
$29.91-3.98%ClosedMarket Cap: $98.0M

As of 2026-07-15

Why PBLS matters now

Parabilis Medicines, Inc. (PBLS) is a US stock in Healthcare. The latest InvestLog snapshot shows $29.91 with -3.98% on the session and $98.0M in market capitalization.

The latest indexable market news headline is "Here Are Monday’s Best Wall Street Analyst Research Calls: Agnico Eagle Mines, Datadog, Delta Air Lines, Gilead Sciences, Okta, Pfizer, Regions Financial, T-Mobile, and More" from 247 Wallst.

Latest News

Here Are Monday’s Best Wall Street Analyst Research Calls: Agnico Eagle Mines, Datadog, Delta Air Lines, Gilead Sciences, Okta, Pfizer, Regions Financial, T-Mobile, and More247 Wallst · 2026-07-06
This Parabilis Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For MondayBenzinga · 2026-07-06
This Little-Known Biotech Just Delivered a Bigger IPO Pop Than SpaceX -- and Regeneron Is Already InvestedThe Motley Fool · 2026-06-27
Fresh Off IPO, A Director Buys $474,000 of Parabilis Medicines Stock. Is PBLS a Buy?The Motley Fool · 2026-06-20
Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional SharesGlobeNewsWire · 2026-06-11

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

NASDAQ

Beta

0.00

Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.